C16 CPG (1-DMT-2-Hexadecyl-Glyc-CPG)
CPG for incorporation of a C16 spacer at the 3' end of an oligonucleotide.
CPG for incorporation of a C16 spacer at the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyuridine base into the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyinosine base into the 3' end of an oligonucleotide.
CPG for incorporation of a C2 spacer at the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyinosine base into the 3' end of an oligonucleotide.
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG used to incorporate a bromo-modified uridine at the 3' end of an oligonucleotide.
CPG for 3' phosphate modification of an oligonucleotide.
CPG used to incorporate a lipophilic palmitoyl-modifier at the 3' end of an oligonucleotide.
CPG for the incorporation of an amino function at the 3' end of an oligonucleotide.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |